Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1)-Reference-Cited by-同舟云学术

Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1)

Published:2017-06-21 Issue:11 Volume:44 Page:1285-1290
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Imafuku Shinichi¹^ORCID,Torisu-Itakura Hitoe²^ORCID,Nishikawa Atsushi²,Zhao Fangyi³,Cameron Gregory S.³,

Affiliation:

1. Department of Dermatology; Faculty of Medicine; Fukuoka University; Fukuoka

2. Lilly Research Laboratories; Eli Lilly Japan K.K.; Kobe Hyogo Japan

3. Lilly Research Laboratories; Eli Lilly and Company; Indianapolis IN USA

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.13927/fullpdf

Reference14 articles.

1. Immunology of psoriasis;Lowes;Annu Rev Immunol,2014

2. Prevalence of dermatological disorders in Japan: a nationwide, cross-sectional, seasonal, multicenter, hospital-based study;Furue;J Dermatol,2011

3. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database;Kubota;BMJ Open,2015

4. Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis;Gordon;N Engl J Med,2016

5. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials;Griffiths;Lancet,2015

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term therapy with itolizumab is safe and effective for patients with moderate to severe psoriasis: Results from an expanded-access program;International Immunopharmacology;2024-06

2. A Systematic Review Evaluating the Effectiveness of Several Biological Therapies for the Treatment of Skin Psoriasis;Cureus;2023-12-15

3. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-07-12

4. Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review;American Journal of Clinical Dermatology;2023-05-20

5. Safety of current systemic therapies for nail psoriasis;Expert Opinion on Drug Safety;2023-05-04